Researching new ways of developing drugs

The beams from the synchrotron have a mind-boggling array of applications. In this instance, they were used to study samples from a Tudor warship, the Mary Rose, and formulate an improved solution to preserve the relic. - Diamond Light Source.

Some machines are heralding a new era of rational drug design.

Prof Andrew Harrison is CEO of Diamond Light Source Ltd, which manages Britain’s national synchrotron facility through funding from the British Government and a research charity called the Wellcome Trust. Diamond is one of 70 such machines around the world, but it’s one of the newest and most advanced.